U.S. stocks continued to follow the lead of overseas markets, moving higher on the prospects of a Greek debt deal. At the closing bell, the broader market averages gained 1.1% to 1.5% across the board. Technology and consumer discretionary names led the way higher on the session.
Elsewhere, the U.S. dollar index gained 80 basis points and the yield on the benchmark 10-year U.S. Treasury note moved 4.2 basis points higher to 2.439%. Natural gas also popped nearly 4%, while the CBOE S&P 500 Volatility Index (VIX) fell more than 17%.
Anacor Pharmaceuticals (ANAC) was the big winner on Monday, gaining 56% following positive results from a clinical trial for an eczema treatment. On the other hand, Ascena Retail (ASNA) fell nearly 13% on a lower earnings outlook. In after-hours action, student loan provider Navient (NAVI) was halted until 4:45 p.m. ET after cutting its profit guidance. (Anacor Pharmaceuticals is on TheStreet's Daily Swing Trade Watch List.)
Looking ahead to Tuesday morning, Johnson & Johnson (JNJ), JPMorgan Chase (JPM) and Wells Fargo (WFC) headline the earnings calendar. On the economic front, we'll get a look at advance retail sales and import prices before the opening bell. (Johnson & Johnson and Wells Fargo are part of TheStreet's Action Alerts PLUS portfolio.)